Dubai, February 9 2022: Alliance Global, headquartered in Dubai, member of the AG Holding group of companies have signed an exclusive distribution agreement with Stilla Technologies, the Boston- and Paris-based multiplex digital PCR company to expand its product offerings into the Middle East, Africa and Central Asia markets and grow the Stilla Technologies customer base.

“We are very happy to establish a strategic partnership with Stilla Technologies for their digital PCR solution, and we believe that their products will add great value to our customers and markets especially for applications like oncology, infectious disease, gene therapy, disease monitoring and food testing.” said Dr. Nassim-Marie Hambouz, Group Vice President of Operations.

Matt Grow, VP Global Sales & Marketing for Stilla commended the new agreement; “We are excited about Stilla’s new strategic distribution partnership with Alliance Global as we extend our global footprint in the Middle East and Africa, we have aligned strategies with Alliance Global, working to improve lives through science”


About Stilla Technologies

Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing.

More on Stilla Technologies


About Alliance Global

Alliance Global is a member of the AGB Distribution Group; the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets.